Literature DB >> 14642366

Interstitial glycerol increase in microdialysis after glycerol enema.

Jan Gliemroth1, Stephan Klaus, Ludger Bahlmann, Anke Klöhn, Kai Duysen, Anja Reith, Hans Arnold.   

Abstract

Microdialysis allows the measurement of extracellular concentrations of various endogenous substances, such as excitotoxic amino acids or metabolic end products. Recent advances in microdialysis techniques have led to widespread use in patients with brain disorders. Microdialysis has proved to be a useful tool for monitoring cerebral biochemical metabolism and secondary brain damage in severe head injury, subarachnoid haemorrhage, stroke, and epilepsy. In our neurosurgical intensive care unit, microdialysis was performed on 42 patients. Four patients received a glycerol enema for therapy of a paralytic ileus. A glycerol peak was observed in both intracerebral and subcutaneous microdialysis occurring three to four hours after the glycerol enema in all four patients. The highest glycerol value was 1187micromol/l cerebral and 2997micromol/l in the subcutaneous tissue. Our study indicates that besides the measurement of serum osmolality and serum glycerol level, microdialysis may be an additional valuable tool to control glycerol therapy in patients with cerebral oedema and elevated intracranial pressure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14642366     DOI: 10.1016/s0967-5868(03)00113-9

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  2 in total

1.  The Role of Glycerol-Containing Drugs in Cerebral Microdialysis: A Retrospective Study on the Effects of Intravenously Administered Glycerol.

Authors:  Maximilian Peter Forssten; Eric Peter Thelin; David W Nelson; Bo-Michael Bellander
Journal:  Neurocrit Care       Date:  2019-06       Impact factor: 3.210

2.  Validation of intraluminal and intraperitoneal microdialysis in ischemic small intestine.

Authors:  Lauri Pynnönen; Minna Minkkinen; Anders Perner; Sari Räty; Isto Nordback; Juhani Sand; Jyrki Tenhunen
Journal:  BMC Gastroenterol       Date:  2013-12-10       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.